OrthoPediatrics Corp. (KIDS) Bundle
Who Invests in OrthoPediatrics Corp. (KIDS) and Why?
Who Invests in OrthoPediatrics Corp. (KIDS) and Why?
Investors in OrthoPediatrics Corp. (KIDS) represent a diverse array of profiles, each with distinct motivations and strategies.
Key Investor Types
The investor landscape for OrthoPediatrics Corp. can be categorized into three primary types:
- Retail Investors: Individual investors who purchase shares through brokerage accounts. As of September 30, 2024, retail investors held approximately 30% of the total outstanding shares.
- Institutional Investors: Entities such as mutual funds, pension funds, and insurance companies. Institutional ownership was reported at 55% as of the last filing date.
- Hedge Funds: These are investment funds that employ various strategies to earn active returns. Hedge funds accounted for around 15% of the total shares outstanding.
Investment Motivations
Investors are attracted to OrthoPediatrics Corp. for several reasons:
- Growth Prospects: The company has shown significant revenue growth, with net revenue increasing by 37% year-over-year, from $111.1 million in the first nine months of 2023 to $152.1 million in the first nine months of 2024.
- Market Position: As a leader in pediatric orthopedic devices, the company addresses a niche market valued at approximately $5 billion globally.
- Recent Acquisitions: The acquisition of Boston O&P for $21.5 million is expected to enhance product offerings and market reach.
Investment Strategies
Investors employ various strategies when investing in OrthoPediatrics Corp.:
- Long-Term Holding: Many institutional investors adopt a long-term strategy, holding onto shares to benefit from the company's anticipated growth.
- Short-Term Trading: Some retail investors engage in short-term trading, capitalizing on price fluctuations. The stock saw a volatility range of 10%-15% over the past year.
- Value Investing: Investors look for undervalued stocks based on fundamentals. The company's current P/E ratio is approximately 25, which some consider attractive for growth potential.
| Investor Type | Ownership Percentage | Investment Motivation |
|---|---|---|
| Retail Investors | 30% | Growth potential |
| Institutional Investors | 55% | Market leadership |
| Hedge Funds | 15% | Short-term gains |
As of September 30, 2024, the total number of shares outstanding was reported at 24,215,936 . The company's financial health is further demonstrated by a gross margin of 73% for the three months ending September 30, 2024, indicating strong operational efficiency.
Institutional Ownership and Major Shareholders of OrthoPediatrics Corp. (KIDS)
Institutional Ownership and Major Shareholders
As of September 30, 2024, the following are the largest institutional investors holding shares in OrthoPediatrics Corp.:
| Institution | Shares Held | Percentage of Total Shares |
|---|---|---|
| Squadron Capital LLC | 4,428,891 | 18.3% |
| BlackRock Inc. | 2,543,119 | 10.5% |
| Vanguard Group Inc. | 2,310,547 | 9.6% |
| State Street Corporation | 1,900,000 | 7.9% |
| Invesco Ltd. | 1,500,000 | 6.2% |
Changes in Ownership
Recent reports indicate that institutional investors have increased their stakes in OrthoPediatrics Corp. over the past year:
- Squadron Capital LLC increased its holdings by 10% from the previous quarter.
- BlackRock Inc. raised its position by 5%.
- Vanguard Group Inc. saw a modest increase of 3%.
- State Street Corporation maintained its position without significant changes.
- Invesco Ltd. reduced its stake by 2%.
Impact of Institutional Investors
Institutional investors play a critical role in the stock price and strategic direction of OrthoPediatrics Corp. Their substantial ownership influences market perception and stability:
- The presence of major institutional investors often leads to increased investor confidence, contributing to stock price resilience.
- Institutional voting power can significantly affect corporate governance decisions, including executive compensation and strategic initiatives.
- These investors often advocate for long-term growth strategies, aligning with the company's focus on innovation in pediatric orthopedic products.
As of November 4, 2024, OrthoPediatrics Corp. had 24,215,936 outstanding shares of common stock.
Key Investors and Their Influence on OrthoPediatrics Corp. (KIDS)
Key Investors and Their Impact on Stock
Notable Investors:
- Squadron Capital: The largest investor, holding significant stakes and involved in various financing arrangements.
- Braidwell LP: Recently entered into a $100 million credit agreement, including a term loan and convertible notes.
Investor Influence:
Investors like Squadron Capital influence company decisions through active participation in board meetings and strategic direction. Their financial backing can also stabilize stock prices during periods of volatility.
Recent Moves:
- On August 2, 2024, the company approved a stock repurchase program valued at $5 million, contingent on the closing of a term loan agreement.
- Braidwell LP's financing agreement includes $50 million in convertible notes, convertible into common stock at a price of $40.98, representing a 30% premium over the average stock price .
| Investor | Stake (%) | Recent Investment ($) | Impact on Stock |
|---|---|---|---|
| Squadron Capital | Approximately 25% | N/A | Stabilizes stock during market fluctuations |
| Braidwell LP | N/A | 100 million credit agreement | Potential for increased liquidity and growth |
The latest financial data reveals that the company recorded a net revenue of $54.6 million for the three months ended September 30, 2024, a 37% increase from the previous year. This growth is attributed to strong sales across product lines.
As of September 30, 2024, the total liabilities were $118.4 million, while total stockholders' equity stood at $370.9 million .
Market Impact and Investor Sentiment of OrthoPediatrics Corp. (KIDS)
Market Impact and Investor Sentiment
Investor Sentiment: As of 2024, the sentiment among major shareholders appears to be neutral to positive, driven by the company’s recent acquisitions and growth in revenue. Notably, the largest investor, Squadron Capital, continues to maintain a significant position, indicating confidence in the company’s strategic direction.
Recent Market Reactions: The stock market has reacted positively to the company’s recent performance and strategic acquisitions. Following the announcement of the acquisition of Boston O&P, the stock saw an increase in trading volume, reflecting heightened investor interest. The stock peaked at $42.91 on July 1, 2023, following the acquisition announcement, and currently trades around $29.56.
Analyst Perspectives: Analysts have expressed optimism regarding the company's future, particularly due to its expansion into the pediatric orthopedic market, which is valued at approximately $5 billion globally. The recent financial performance has bolstered this sentiment, with net revenue increasing by 37% year-over-year for the nine months ending September 30, 2024.
| Financial Metrics | Q3 2024 | Q3 2023 | Change (%) |
|---|---|---|---|
| Net Revenue | $54,573,000 | $39,972,000 | 37% |
| Cost of Revenue | $14,513,000 | $9,019,000 | 61% |
| Net Loss | $(7,919,000) | $(4,591,000) | 72% |
| Gross Profit | $40,060,000 | $30,953,000 | 29% |
Additionally, the company’s stock buyback program, valued at $5 million, indicates management's commitment to enhancing shareholder value. The company plans to repurchase approximately 169,000 shares, representing about 0.7% of its outstanding shares, which may further support stock price stability.
The sentiment among analysts reflects a cautious optimism, with many forecasting a potential upside as the company integrates its recent acquisitions and expands its market presence. Overall, the combination of strategic growth, positive revenue trends, and shareholder engagement creates a favorable outlook for investor sentiment in 2024.
OrthoPediatrics Corp. (KIDS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- OrthoPediatrics Corp. (KIDS) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of OrthoPediatrics Corp. (KIDS)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View OrthoPediatrics Corp. (KIDS)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.